PEG-stearate coated solid lipid nanoparticles as levothyroxine carriers for oral administration

Journal of Nanoparticle Research

Volumn 16, Issue 3, 2014, Pages

  Kashanian, Soheila ^a   Rostami, Elham ^b  

^a RAZI UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Levothyroxine sodium; Microemulsion; Nanomedicine; PEGylation; Solid lipid nanoparticles

Indexed keywords

DIFFERENTIAL SCANNING CALORIMETRY; EMULSIFICATION; ETHYLENE; ETHYLENE GLYCOL; MEDICAL NANOTECHNOLOGY; MICROEMULSIONS; MORPHOLOGY; NANOPARTICLES; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PLASTIC COATINGS; SCANNING ELECTRON MICROSCOPY; SOLS; SURFACE MORPHOLOGY; TARGETED DRUG DELIVERY; ZETA POTENTIAL;

COLLOIDAL CARRIERS; CRITICAL AGGREGATION; LIPID NANOPARTICLES; MICROEMULSIFICATION; NANOPARTICLE SYSTEMS; ORAL ADMINISTRATION; PEGYLATION; SOLID LIPID NANOPARTICLE (SLN);

CONTROLLED DRUG DELIVERY;

LEVOTHYROXINE SODIUM; MACROGOL STEARATE; PALMITIC ACID; SOLID LIPID NANOPARTICLE; TRIACYLGLYCEROL; TRIPALMITIN;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG COATING; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; OPTICAL DENSITY; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84894247697     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-014-2293-6     Document Type: Article

References (55)

1. Abdelbary G, Fahmy RH (2009) Diazepam-loaded solid lipid nanoparticles: design and characterization. AAPS Pharm SciTech 10(1):211-219
2. Barzegar-Jalali M, Adibkia K, Valizadeh H, Siahi-Shadbad MR, Nokhodchi A, Omidi Y, Mohammadi G, Hallaj-Nezhad S, Hasan M (2008) Kinetic analysis of drug release from nanoparticles. J Pharm Pharm Sci 11(1):167-177
3. Bhaskar K, Anbu J, Ravichandiran V, Venkateswarlu V, Rao YM (2009) Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies. Lipids Health Dis 8(6):1-15
4. Blakesley VA (2005) Current methodology to assess bio-equivalence of levothyroxine sodium products is inadequate. AAPS J 7(1):122-128
5. Bocca C, Caputo O, Cavalli R, Gabriel L, Miglietta A, Gasco MR (1998) Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles. Int J Pharm 175(2):185-193 (Pubitemid 28517974)
6. Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF (2002) Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 238(1-2):241-245 (Pubitemid 34457892)
7. Cavalli R, Bargoni A, Podio V, Muntoni E, Zara GP, Gasco MR (2003) Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin. J Pharm Sci 92(5):1085-1094 (Pubitemid 36523455)
8. Chimmiri P, Rajalakshmi R, Mahitha B, Ramesh G, Noor Ahmed VH (2012) Solid lipid nanoparticles: a novel carrier for cancer therapy. Int J Biol Pharm Res 3(3):405-413
9. Collier JW, Shah RB, Bryant AR, Habib MJ, Khan MA, Faustino PJ (2011) Development and application of a validated HPLC method for the analysis of dissolution samples of levothyroxine sodium drug products. J Pharm Biomed Anal 54(3):433-438
10. Dadashzadeh S, Derakhshandeh K, Shirazi FH (2008) 9-Nitro-camptothecin polymeric nanoparticles: cytotoxicity and pharmacokinetic studies of lactone and total forms of drug in rats. Anticancer Drugs 19(8):805-811
11. Damge C, Michel C, Aprahamian M, Couvreur P, Devissaguet JP (1990) Nanocapsules as carriers for oral peptide delivery. J Control Release 13(2-3):233-239 (Pubitemid 20313521)
12. Derakhshandeh K, Erfan M, Dadashzadeh S (2007) Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics. Eur J Pharm Biopharm 66(1):34-41 (Pubitemid 46412968)
13. Derakhshandeh K, Soheili M, Dadashzadeh S, Saghiri R (2010) Preparation and in vitro characterization of 9-nitrocamptothecin loaded long circulating nanoparticles for delivery of to cancer. Int J Nanomedicine 5(1):1-9
14. Desai MP, Labhasetwar V, Amidon GL, Levy RL (1996) Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 13(12):1838-1845 (Pubitemid 27034116)
15. Ekambaram P, Sathali AAH, Priyanka K (2012) Solid lipid nanoparticles: a review. Sci Rev Chem Commun 2(1):80-102
16. Fang YP, Wu PC, Huang YB, Tzeng CC, Chen YL, Hung YH, Tsai MJ, Tsai YH (2012) Modification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery. Int J Nanomedicine 7:4995-5005
17. Florence AT (1997) The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm Res 14(3):259-266
18. Garcia-Fuentes M, Torres D, Alonso MJ (2002) Design of lipid nanoparticles for the oral delivery of hydrophilic macro-molecules. Colloids Surf B 27(2-3):159-168
19. Garcia-Fuentes M, Torres D, Alonso MJ (2005a) Design and characterization of a new drug nanocarriermade from solid-liquid lipid mixtures. J Colloid Interf Sci 285(2):590-598 (Pubitemid 40544678)
20. Garcia-Fuentes M, Torres D, Alonso MJ (2005b) New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin. Int J Pharm 296(1-2):122-132 (Pubitemid 40693381)
21. Garcia-Fuentes M, Prego C, Torres D, Alonso MJ (2005c) A comparative study of the potential of solid glyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery. Eur J Pharm Sci 25(1):133-143 (Pubitemid 40602203)
22. Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Muller RH (2000) 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B 18(3-4):301-313 (Pubitemid 30479870)
23. Gregorini A, Ruiz ME, Volonté MG (2013) A derivative UV spectrophotometric method for the determination of levothyroxine sodium in tablets. J Anal Chem 68(6):510-515
24. Hans ML, Lowman AM (2002) Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 6(4):319-327 (Pubitemid 36238389)
25. Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP (2003) Physico-chemical stability of colloidal lipid particles. Biomaterials 24(23):283-300
26. Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S (2005) Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B 45(3-4):167-173 (Pubitemid 41415646)
27. Jani PU, Halbert GW, Langridge J, Florence AT (1990) Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol 42(12):821-826
28. Kashanian S, Azandaryani HA, Derakhshandeh K (2011) New surface modified solid lipid nanoparticles by using N-glutaryl phosphatidyl ethanolamine as outer shell. Int J Nanomedicine 6:1-9
29. Khalil R, Kassem M, Elbary AA, ElRidi M, AbouSamra M (2013) Preparation and characterization of nystatin-loaded solid lipid nanoparticles for topical delivery. Int J Pharm Sci Res 4(6):2292-2300
30. Khan S (2012) Solid lipid nanoparticles: a review. World J Pharm Pharm Sci 1(1):96-115
31. Lai F, Sinico C, De LA, Zaru M, Müller RH, Fadda AM (2007) SLN as a topical delivery system for Artemisia arborescens essential oil: in vitro antiviral activity and skin permeation study. Int J Nanomedicine 2(3):419-425 (Pubitemid 350047785)
32. Li XW, Lin XH, Zheng L, Yu L, Lv FF, Zhang Q, LiuW(2008) Effect of poly (ethylene glycol) stearate on the phase behavior of monocaprate/tween80/water system and characterization of poly (ethylene glycol) stearate-modified solid lipid nanoparticles. Colloids Surf A 317(1-3):352-359
33. Lilja JJ, Laitinen K, Neuvonen PJ (2005) Effects of grapefruit juice on the absorption of levothyroxine. Brit J Clin Pharmacol 60(3):337-341 (Pubitemid 41224144)
34. Liu J, Gong T, Wang C, Zhong Z, Zhang Z (2007) Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm 340(1-2):153-162 (Pubitemid 47044961)
35. Liu W, Hu M, Liu W, Xue C, Xu H, Yang XL (2008) Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetate. Int J Pharm 364(1):135-141
36. Lowe PL, Temple CS (1994) Calcitonin and insulin in isobutyl cyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption. J Pharm Pharmacol 46(7):547-552
37. Muller RH, Mader K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery-are view of the state of the art. Eur J Pharm Biopharm 50(1):161-177 (Pubitemid 30326695)
38. Parhi R, Suresh P (2010) Production of solid lipid nanoparticles-drug loading and release mechanism. J Chem Pharm Res 2(1):211-227
39. Prego C, Torres D, Fernandez-Megia E, Novoa-Carballal R, Quiñoá E, Alonso MJ (2006) Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree. J Controlled Release 111(3):299-308
40. Rapaka RS, Roth J, Brine GA, Prasad VK (1982) A simple HPLC method for the dissolution studies on levothyroxine sodium tablets. Int J Pharm 12(4):285-294 (Pubitemid 13235966)
41. Sarmento B, Martins S, Ferreira D, Souto EB (2007) Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomedicine 2(4):743-749
42. Shah RB, Bryant A, Collier J, Habib MJ, Khan MA (2008) Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients. Int J Pharm 360(1-2):77-82
43. Singhvi G, Singh M (2011) Review: in vitro drug release characterization models. Int J Pharm Stud Res 2(1):77-84
44. Souto EB, Wissing SA, Barbosa CM, Müller RH (2004) Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 278(1):71-77
45. Subedi RK, Kang KW, Choi HK (2009) Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci 37(3-4):508-513
46. Svensson J, Ericsson UB, Nilsson P, Olsson C, Jonsson B, Lindberg B, Ivarsson S (2006) Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. J Clin Endocrinol Metab 91(5):1729-1734
47. Uner M, Yener G (2007) Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine 2(3):289-300 (Pubitemid 350047774)
48. Vila A, Sanchez A, Tob?oM, Calvo P, Alonso MJ (2002) Design of biodegradable particles for protein delivery. J Controlled Release 78(1-3):15-24 (Pubitemid 34081849)
49. Vila A, Sanchez A, Evora C, Soriano I, Vila Jato JL, Alonso MJ (2004) PEG-PLA nanoparticles as carriers for nasal vaccine delivery. J Aerosol Med 17(2):174-185 (Pubitemid 38955679)
50. Volpato NM, Silva RL, Brito APP, Gonçalves JCS, Vaisman M, Noël F (2004) Multiple level C in vitro/in vivo correlation of dissolution profiles of two l-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism. Eur J Pharm Sci 21(5):655-660 (Pubitemid 38447147)
51. Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ (1999) Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on the brain. J Control Release 59(3):299-307 (Pubitemid 29238174)
52. Zara GP, Bargoni A, Cavalli R, Fundaro A, Vighetto D, Gasco MR (2002) Pharmaco- kinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats. J Pharm Sci 91(5):1324-1333 (Pubitemid 34651194)
53. Zhang Q, Yie G, Li Y, Yang Q, Nagai T (2000) Studies on the cyclosporine A loaded stearic acid nanoparticles. Int J Pharm 200(2):153-159 (Pubitemid 30364902)
54. Zhang N, Ping QN, Huang GH, Xua WF (2005) Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm 294(1-2):247-259 (Pubitemid 40462339)
55. Zhang C, Gu C, Peng F, Liu W, Wan J, Xu H, Lam CW, Yang X (2013) Preparation and optimization of triptolide-loaded solid lipid nanoparticles for oral delivery with reduced gastric irritation. Molecules 18(11):13340-13356